CC BY 4.0 · TH Open 2022; 06(03): e283-e290
DOI: 10.1055/s-0042-1755617
Original Article

Predictors of Adherence to Stroke Prevention in the BALKAN-AF Study: A Machine-Learning Approach

Monika Kozieł-Siołkowska
1   Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
2   1st Department of Cardiology and Angiology, Silesian Centre for Heart Diseases, Zabrze, Poland
,
Sebastian Siołkowski
1   Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
,
Miroslav Mihajlovic
3   Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia
,
1   Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
2   1st Department of Cardiology and Angiology, Silesian Centre for Heart Diseases, Zabrze, Poland
4   School of Medicine, Belgrade University, Belgrade, Serbia
5   Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
,
3   Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia
4   School of Medicine, Belgrade University, Belgrade, Serbia
,
on behalf of the BALKAN-AF Investigators › Author Affiliations
Funding BALKAN-AF was not sponsored or funded.

Abstract

Background Compared with usual care, guideline-adherent stroke prevention strategy, based on the ABC (Atrial fibrillation Better Care) pathway, is associated with better outcomes. Given that stroke prevention is central to atrial fibrillation (AF) management, improved efforts to determining predictors of adherence with ‘A’ (avoid stroke) component of the ABC pathway are needed.

Purpose We tested the hypothesis that more sophisticated methodology using machine learning (ML) algorithms could do this.

Methods In this post-hoc analysis of the BALKAN-AF dataset, ML algorithms and logistic regression were tested. The feature selection process identified a subset of variables that were most relevant for creating the model. Adherence with the ‘A’ criterion of the ABC pathway was defined as the use of oral anticoagulants (OAC) in patients with AF with a CHA2DS2-VASc score of 0 (male) or 1 (female).

Results Among 2,712 enrolled patients, complete data on ‘A’-adherent management were available in 2,671 individuals (mean age 66.0 ± 12.8; 44.5% female). Based on ML algorithms, independent predictors of ‘A-criterion adherent management’ were paroxysmal AF, center in capital city, and first-diagnosed AF. Hypertrophic cardiomyopathy, chronic kidney disease with chronic dialysis, and sleep apnea were independently associated with a lower likelihood of ‘A’-criterion adherent management.

ML evaluated predictors of adherence with the ‘A’ criterion of the ABC pathway derived an area under the receiver-operator curve of 0.710 (95%CI 0.67–0.75) for random forest with fine tuning.

Conclusions Machine learning identified paroxysmal AF, treatment center in the capital city, and first-diagnosed AF as predictors of adherence to the A pathway; and hypertrophic cardiomyopathy, chronic kidney disease with chronic dialysis, and sleep apnea as predictors of non adherence.

* Joint senior authors.




Publication History

Received: 13 May 2022

Accepted: 27 June 2022

Article published online:
23 September 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Hindricks G, Potpara T, Dagres N. et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021; 42 (05) 373-498
  • 2 Potpara TS, Lip GYH, Blomstrom-Lundqvist C. et al. The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation. Thromb Haemost 2021; 121 (03) 270-278
  • 3 Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 2017; 14 (11) 627-628
  • 4 Romiti GF, Pastori D, Rivera-Caravaca JM. et al. Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients. Thromb Haemost 2022; 122 (03) 406-414
  • 5 Yoon M, Yang PS, Jang E. et al. Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study. Thromb Haemost 2019; 119 (10) 1695-1703
  • 6 Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH. Improved Outcomes by Integrated Care of Anticoagulated Patients with Atrial Fibrillation Using the Simple ABC (Atrial Fibrillation Better Care) Pathway. Am J Med 2018; 131 (11) 1359-1366.e6
  • 7 Proietti M, Lip GYH, Laroche C. et al; ESC-EORP Atrial Fibrillation General Long-Term Registry Investigators Group. Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry. Europace 2021; 23 (02) 174-183
  • 8 Olier I, Ortega-Martorell S, Pieroni M, Lip GYH. How machine learning is impacting research in atrial fibrillation: implications for risk prediction and future management. Cardiovasc Res 2021; 117 (07) 1700-1717
  • 9 Potpara TS, Lip GY. , Balkan-AF Investigators. Patterns in atrial fibrillation management and ‘real-world’ adherence to guidelines in the Balkan Region: an overview of the Balkan–atrial fibrillation survey. Eur Heart J 2015; 36 (30) 1943-1944
  • 10 Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137 (02) 263-272
  • 11 Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138 (05) 1093-1100
  • 12 Potpara TS, Dan GA, Trendafilova E. et al; BALKAN-AF Investigators. Stroke prevention in atrial fibrillation and ‘real world’ adherence to guidelines in the Balkan Region: The BALKAN-AF Survey. Sci Rep 2016; 6: 20432
  • 13 Kozieł M, Simovic S, Pavlovic N. et al. Adherence to the ABC (Atrial fibrillation Better Care) pathway in the Balkan region: the BALKAN-AF survey. Pol Arch Intern Med 2020; 130 (03) 187-195
  • 14 Heidbuchel H, Dagres N, Antz M. et al. Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment. Europace 2018; 20 (12) 1919-1928
  • 15 Jones NR, Crawford W, Yang Y. et al. A Systematic Review of Economic Aspects of Service Interventions to Increase Anticoagulation Use in Atrial Fibrillation. Thromb Haemost 2022; 122 (03) 394-405
  • 16 Pritchett RV, Bem D, Turner GM. et al. Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review. Thromb Haemost 2019; 119 (02) 294-307
  • 17 Roldán V, Marín F, Manzano-Fernández S. et al. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 2013; 62 (23) 2199-2204
  • 18 Borre ED, Goode A, Raitz G. et al. Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review. Thromb Haemost 2018; 118 (12) 2171-2187
  • 19 Lip GY, Laroche C, Dan GA. et al. ‘Real-world’ antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Am J Med 2014; 127 (06) 519-29.e1
  • 20 Lip GYH, Laroche C, Popescu MI. et al. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. Europace 2015; 17 (12) 1777-1786
  • 21 Olesen JB, Lip GY, Kamper AL. et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012; 367 (07) 625-635
  • 22 Potpara TS, Ferro CJ, Lip GYH. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction. Nat Rev Nephrol 2018; 14 (05) 337-351
  • 23 Camm AJ, Lip GY, De Caterina R. et al; ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33 (21) 2719-2747
  • 24 Kirchhof P, Nabauer M, Gerth A. et al; AFNET registry investigators. Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Thromb Haemost 2011; 105 (06) 1010-1023
  • 25 Dupree L, DeLosSantos M, Smotherman C. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge. J Cardiovasc Pharmacol Ther 2018; 23 (06) 502-508
  • 26 Proietti M, Laroche C, Opolski G, Maggioni AP, Boriani G, Lip GYH. AF Gen Pilot Investigators. ‘Real-world’ atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase. Europace 2017; 19 (05) 722-733
  • 27 Lip GYH, Tran G, Genaidy A, Marroquin P, Estes C, Landsheftl J. Improving dynamic stroke risk prediction in non-anticoagulated patients with and without atrial fibrillation: Comparing common clinical risk scores and machine learning algorithms. Eur Heart J Qual Care Clin Outcomes 2021; qcab037
  • 28 Lip GYH, Genaidy A, Tran G, Marroquin P, Estes C, Sloop S. Improving Stroke Risk Prediction in the General Population: A Comparative Assessment of Common Clinical Rules, a New Multimorbid Index, and Machine-Learning-Based Algorithms. Thromb Haemost 2022; 122 (01) 142-150
  • 29 Guo Y. A New Paradigm of “Real-Time” Stroke Risk Prediction and Integrated Care Management in the Digital Health Era: Innovations Using Machine Learning and Artificial Intelligence Approaches. Thromb Haemost 2022; 122 (01) 5-7